<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-148032" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Inappropriate Medication in the Geriatric Population</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cojuc-Konigsberg</surname>
            <given-names>Gabriel</given-names>
          </name>
          <aff>Universidad An&#x000e1;huac M&#x000e9;xico and Instituto Nacional de Ciencias M&#x000e9;dicas y Nutrici&#x000f3;n Salvador Zubir&#x000e1;n.</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schoo</surname>
            <given-names>Caroline</given-names>
          </name>
          <aff>VOA PACE</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Gabriel Cojuc-Konigsberg declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Caroline Schoo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-148032.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Potentially inappropriate medications are drugs that pose a risk of causing adverse events. Many tools, such as the American Geriatrics Society Beers Criteria&#x000ae;, have been developed to assess potentially inappropriate medications in the geriatric population. The latest version of the AGS Beers Criteria&#x000ae; was revised in 2019 to assist practicing clinicians in outpatient, acute, and institutional settings. It includes medications evaluated in 5 main categories: drugs to avoid, drugs to use with caution, drug-drug interactions, medications to avoid in particular clinical situations, and dosage according to kidney function. This activity illustrates the main issues concerning inappropriate medication use in the geriatric population and highlights the interprofessional team's role in improving patient care.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the importance of inappropriate medication use in the geriatric population and summarize the risks associated with inappropriate medication use.</p></list-item><list-item><p>Evaluate&#x000a0;the basis, utilization, advantages, and limitations of the AGS Beers Criteria.</p></list-item><list-item><p>Assess&#x000a0;relevant strategies to assess geriatric patients with potentially inappropriate medications.</p></list-item><list-item><p>Communicate&#x000a0;the interprofessional interventions for evaluating and preventing inappropriate medication use in older adults.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=148032&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=148032">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-148032.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Potentially inappropriate medications (PIM) can be defined as drugs&#x000a0;that pose an increased&#x000a0;risk of causing adverse events.<xref ref-type="bibr" rid="article-148032.r1">[1]</xref>&#x000a0;The American Geriatrics Society Beers Criteria&#x000ae; is a set of recommendations for avoiding&#x000a0;PIMs in the geriatric population.<xref ref-type="bibr" rid="article-148032.r2">[2]</xref>&#x000a0;Initially published in 1991, the AGS Beers Criteria&#x000ae; has been periodically updated to provide more accurate and practical guidelines for healthcare providers.<xref ref-type="bibr" rid="article-148032.r3">[3]</xref><xref ref-type="bibr" rid="article-148032.r4">[4]</xref><xref ref-type="bibr" rid="article-148032.r1">[1]</xref>&#x000a0;The&#x000a0;AGS Beers Criteria&#x000ae;&#x000a0;is consistently revised by an interprofessional team utilizing an evidence-based approach.<xref ref-type="bibr" rid="article-148032.r3">[3]</xref><xref ref-type="bibr" rid="article-148032.r5">[5]</xref>&#x000a0;The latest version of the&#x000a0;AGS Beers Criteria&#x000ae; was written in 2019 to&#x000a0;assist practicing clinicians in outpatient, acute, and institutional settings. It includes medications evaluated in 5 main categories: drugs to avoid, drugs to use with caution, drug-drug interactions, medications to avoid in particular clinical situations, and dosage according to kidney function.<xref ref-type="bibr" rid="article-148032.r3">[3]</xref>&#x000a0;The AGS Beers Criteria&#x000ae; is a guideline for practitioners to improve prescriptions, outcomes, and quality of care. Although this list is a comprehensive&#x000a0;guide for clinicians, nurses, pharmacists, patients, and their families, it complements clinical judgment as each scenario is unique.<xref ref-type="bibr" rid="article-148032.r3">[3]</xref>&#x000a0;This&#x000a0;topic presents the main issues of concern, clinical significance, and interprofessional aspects of the AGS Beers Criteria&#x000ae;.</p>
      </sec>
      <sec id="article-148032.s3" sec-type="Function">
        <title>Function</title>
        <p>
<bold>Rationale: Potentially Inappropriate Medication</bold>
</p>
        <p>Polypharmacy is associated with an increased incidence of adverse drug events, decreased functional status, and increased healthcare costs. A relationship between PIM and multiple geriatric syndromes (eg, falls, cognitive decline, urinary retention) has been&#x000a0;established. Adverse&#x000a0;effects are&#x000a0;1 of the leading causes of hospitalization in geriatric patients in the United States and Canada.<xref ref-type="bibr" rid="article-148032.r6">[6]</xref>&#x000a0;Explicit tools such as the AGS Beers Criteria&#x000ae; and STOPP/START criteria are designed to reduce complications caused by PIM. Nonetheless, inappropriate prescriptions are still common, with several studies demonstrating that around half of the geriatric population takes at least&#x000a0;1 medication included in these lists.<xref ref-type="bibr" rid="article-148032.r7">[7]</xref><xref ref-type="bibr" rid="article-148032.r8">[8]</xref>&#x000a0;The use of multiple medications, long durations of treatment, and shared mechanisms of action are associated with higher morbidity, particularly regarding falls and functional capacity. Drugs such as diuretics and other antihypertensives, sedatives, and antipsychotics contribute to the high incidence of adverse effects. Moreover, there is an important correlation between polypharmacy and frailty.<xref ref-type="bibr" rid="article-148032.r9">[9]</xref><xref ref-type="bibr" rid="article-148032.r10">[10]</xref><xref ref-type="bibr" rid="article-148032.r11">[11]</xref>&#x000a0;Although an objective reduction in mortality or improvement in quality of life is yet to be proven, it is understood that addressing polypharmacy and optimizing pharmacological treatment contribute to better patient outcomes. The ongoing POLITE-RCT trial attempts to prove this relationship directly via critical primary and secondary interprofessional interventions.<xref ref-type="bibr" rid="article-148032.r6">[6]</xref><xref ref-type="bibr" rid="article-148032.r12">[12]</xref></p>
      </sec>
      <sec id="article-148032.s4" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>Epidemiology</bold>
</p>
        <p>The prevalence of potentially inappropriate medication use in the geriatric population varies widely depending on geographical, institutional, cultural, and idiosyncratic factors.<xref ref-type="bibr" rid="article-148032.r13">[13]</xref> Studies report that around 40% of adults older than 65 are prescribed at least&#x000a0;1 medication included in the&#x000a0;AGS Beers Criteria&#x000ae;.<xref ref-type="bibr" rid="article-148032.r4">[4]</xref>&#x000a0;Antianxiety (benzodiazepines) and antidepressant (selective serotonin reuptake inhibitors and tricyclic antidepressants) drugs are the most commonly included, particularly in nursing homes and long-term care facilities.<xref ref-type="bibr" rid="article-148032.r13">[13]</xref><xref ref-type="bibr" rid="article-148032.r14">[14]</xref>&#x000a0;The most important predictor for PIM use is polypharmacy, which is present in up to 91% of long-term care facility patients. Other factors, such as female sex and comorbidity, are associated with PIM risks.<xref ref-type="bibr" rid="article-148032.r1">[1]</xref><xref ref-type="bibr" rid="article-148032.r15">[15]</xref><xref ref-type="bibr" rid="article-148032.r14">[14]</xref> Dementia is associated with an 11% increase in PIM use.<xref ref-type="bibr" rid="article-148032.r3">[3]</xref></p>
        <p>
<bold>Aging, Pharmacokinetics, and Pharmacodynamics</bold>
</p>
        <p>The epidemiological transition has led to an aging population, with a significant increase in chronic conditions and a need for geriatric care. Older adults are at increased risk for adverse drug effects due to comorbidities and changes in the pharmacokinetics and pharmacodynamics associated with aging.<xref ref-type="bibr" rid="article-148032.r6">[6]</xref>&#x000a0;Until recent years, clinical trials failed to include significant numbers of geriatric patients, and results were not validated for all populations.<xref ref-type="bibr" rid="article-148032.r16">[16]</xref>&#x000a0;The main age-related changes in pharmacokinetics are a decrease in first-pass metabolism, variations in the volume of distribution due to sarcopenia, and progressive renal function decline.&#x000a0;These and other disease-related changes make drug responses challenging to predict. These factors vary from patient to patient and are not linearly related to age or disease progression. Therefore, drug administration should be individualized, considering goals, indications, and expectations.<xref ref-type="bibr" rid="article-148032.r16">[16]</xref></p>
        <p>
<bold>Polypharmacy</bold>
</p>
        <p>Polypharmacy is classically defined as the use of 5 or more medications by a single patient in a chronic manner. However, utilizing a numerical cutoff does not account for many factors involving this concept, and thus, qualitative definitions should be considered. Polypharmacy includes using multiple inappropriate, unwarranted, and harmful medications.<xref ref-type="bibr" rid="article-148032.r16">[16]</xref><xref ref-type="bibr" rid="article-148032.r17">[17]</xref>&#x000a0;Medication appropriateness encompasses adequacy, cost-effectiveness, the patient's preferences, comorbidities, cognitive states, and treatment goals. Patients with multiple comorbidities, attending physicians, and residing in assisted-living facilities are at a higher risk of suffering from polypharmacy.<xref ref-type="bibr" rid="article-148032.r15">[15]</xref>&#x000a0;</p>
        <p>
<bold>The Prescribing Cascade</bold>
</p>
        <p>The prescribing cascade is a term coined in the late 20th Century by Rochon and Gurwitz; it entails the utilization of&#x000a0;1 or more drugs to prevent or treat the side effects caused by another medication. For instance, when prescribing a non-steroidal anti-inflammatory drug, physicians often add a proton pump inhibitor to prevent gastrointestinal bleeding, or when using opioids to treat pain, a laxative is given to treat opioid-induced constipation. The prescribing cascade should be avoided when possible, considering the risks and benefits of adding multiple medications to a patient's pill burden.<xref ref-type="bibr" rid="article-148032.r15">[15]</xref><xref ref-type="bibr" rid="article-148032.r16">[16]</xref>&#x000a0;Some consequences of polypharmacy and the prescribing cascade are provoking drug-drug interactions, potentiation of adverse effects, frailty, geriatric syndromes, cost burden, and negative outcomes.<xref ref-type="bibr" rid="article-148032.r16">[16]</xref></p>
        <p>
<bold>Inappropriate Prescriptions</bold>
</p>
        <p>The spectrum of inadequate drug prescriptions ranges from misprescribing to underprescribing and overprescribing. Misprescription occurs when the risk of adverse effects of medication significantly outweighs its clinical benefits, including incorrect&#x000a0;dosing or drug combinations. Underprescription is the omission of an indicated drug. Overprescription is the introduction of a drug not indicated for treating a condition.<xref ref-type="bibr" rid="article-148032.r1">[1]</xref><xref ref-type="bibr" rid="article-148032.r5">[5]</xref></p>
        <p>
<bold>Awareness and Prevention</bold>
</p>
        <p>The relevance of the AGS Beers Criteria&#x000ae; relies on professional awareness. Many approaches have been described to reduce the use of PIM and reach the goal of informed, safer prescribing practices. Explicit and implicit criteria should be utilized to assess patients holistically.<xref ref-type="bibr" rid="article-148032.r5">[5]</xref>&#x000a0;The AGS Beers Criteria&#x000ae; names potentially, not definitively, inappropriate medications and should be applied with a comprehensive understanding of each patient's clinical scenario and the medication in question.<xref ref-type="bibr" rid="article-148032.r4">[4]</xref><xref ref-type="bibr" rid="article-148032.r3">[3]</xref>&#x000a0;A comprehensive geriatric assessment should be performed when possible, evaluating the individual's functional, cognitive, social, and health status. In addition, automatized warnings and reviews could be implemented in digital health records to address potential mistakes.<xref ref-type="bibr" rid="article-148032.r5">[5]</xref><xref ref-type="bibr" rid="article-148032.r18">[18]</xref>&#x000a0;Comprehensive medication monitoring and pharmacovigilance are innovative strategies that prevent adverse drug effects. Implementing these systems, which physician assistants,&#x000a0;students, and other healthcare professionals can track at discharge and in the ambulatory setting, leads to further awareness among attending physicians.<xref ref-type="bibr" rid="article-148032.r16">[16]</xref></p>
      </sec>
      <sec id="article-148032.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>How to Apply the&#x000a0;AGS Beers Criteria&#x000ae;?</bold>
</p>
        <p>The AGS Beers Criteria&#x000ae; evaluates&#x000a0;5 aspects of PIM: drugs to avoid, drugs to use with caution, drug interactions, medications to avoid in particular situations, and dosage according to kidney function. These aspects should be considered when prescribing single or multiple drug regimens in older adults.<xref ref-type="bibr" rid="article-148032.r3">[3]</xref>&#x000a0;There are&#x000a0;7 key points to apply the AGS Beers Criteria&#x000ae; with real-world judgment, entitled "Using Wisely," which include utilizing the criteria as guidelines for a patient-centered approach.<xref ref-type="bibr" rid="article-148032.r19">[19]</xref><xref ref-type="bibr" rid="article-148032.r20">[20]</xref>&#x000a0;These include:</p>
        <table-wrap id="article-148032.table0" position="float" orientation="portrait">
          <table style="height: 457px; width: 765px;" border="1" cellspacing="0.5" cellpadding="5">
            <tbody>
              <tr style="height: 35px;">
                <td style="height: 35px; width: 750px; text-align: center;" rowspan="1" colspan="1">
<p><bold>Key principles to guide optimal use of the American Geriatrics Society Beers Criteria&#x000ae;</bold></p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px; width: 750px;" rowspan="1" colspan="1">
<p>1. Medications in the 2019 AGS Beers Criteria&#x000ae; are potentially inappropriate, not definitely inappropriate.</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px; width: 750px;" rowspan="1" colspan="1">
<p>2. Read the rationale and recommendations statements for each criterion. The caveats and guidance listed there are important.</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px; width: 750px;" rowspan="1" colspan="1">
<p>3. Understand why medications are included in the AGS Beers Criteria&#x000ae; and adjust your approach to those medications accordingly.</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px; width: 750px;" rowspan="1" colspan="1">
<p>4. Optimal application of the AGS Beers Criteria&#x000ae; involves identifying&#x000a0;PIMS and, where appropriate, offering safer nonpharmacologic and pharmacologic therapies.</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px; width: 750px;" rowspan="1" colspan="1">
<p>5. The AGS Beers Criteria&#x000ae; should be a starting point for a comprehensive process of identifying and improving medication appropriateness and safety.</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px; width: 750px;" rowspan="1" colspan="1">
<p>6. Access to medications included in the AGS Beers Criteria&#x000ae; should not be excessively restricted by prior authorization&#x000a0;or health plan coverage policies.</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px; width: 750px;" rowspan="1" colspan="1">
<p>7. The AGS Beers Criteria&#x000ae; are not equally applicable to all countries.</p>
</td>
              </tr>
              <tr style="height: 60px;">
                <td style="height: 60px; width: 750px;" rowspan="1" colspan="1">
<p><italic toggle="yes">Adapted with permission from Steinman MA, Fick DM. Using Wisely: A reminder on how to properly use the American Geriatrics Society Beers Criteria&#x000ae;.</italic><xref ref-type="bibr" rid="article-148032.r19">[19]</xref></p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<bold>Aspects to Evaluate in a Medical Visit</bold>
</p>
        <p>The assessment and evaluation of patients in an integral, multi-dimensional fashion is necessary to avoid adverse drug events. Optimal medication prescription is paramount when treating older adults. Many protocols, such as the Assess, Review, Minimize, Optimize, Reassess (ARMOR) and the Prescribing Optimization Method (POM), attempt to standardize and guide these processes. However, these have not been validated.<xref ref-type="bibr" rid="article-148032.r17">[17]</xref>&#x000a0;A stepwise approach to treatment implementation is recommended. There are several key points to evaluate when encountering these situations to avoid inappropriate prescriptions.<xref ref-type="bibr" rid="article-148032.r17">[17]</xref><xref ref-type="bibr" rid="article-148032.r16">[16]</xref>&#x000a0;These include:</p>
        <list list-type="bullet">
          <list-item>
            <p>First, is there a clear indication for administering the medication?</p>
          </list-item>
          <list-item>
            <p>Do the benefits of the drug outweigh the potential harms?</p>
          </list-item>
          <list-item>
            <p>Do any of the medicines present significant interactions?</p>
          </list-item>
          <list-item>
            <p>Is the indicated duration of treatment appropriate?</p>
          </list-item>
          <list-item>
            <p>Are there any duplicated drugs?</p>
          </list-item>
          <list-item>
            <p>Is there a need for renal-adjusted dosage?</p>
          </list-item>
          <list-item>
            <p>Is there a non-pharmacological alternative to avoid PIM?</p>
          </list-item>
          <list-item>
            <p>What is the patient's functional status?</p>
          </list-item>
          <list-item>
            <p>What are the patient's preferences?</p>
          </list-item>
          <list-item>
            <p>Is the patient adherent to their treatment?</p>
          </list-item>
        </list>
        <p>These questions are helpful when assessing PIM and implementing prescription management programs. The patient must be involved in decision-making.<xref ref-type="bibr" rid="article-148032.r16">[16]</xref>&#x000a0;Some helpful strategies to prevent adverse events include monitoring drug efficacy, assessing drug-drug interactions, avoiding overprescription, and periodically monitoring a patient's pharmacological treatment. Other essential aspects of assessing are reviewing adherence and dosage formulations. For example, certain patients might chew, spit, or combine their medication with food, affecting effectiveness. Moreover, patients with swallowing difficulties might find it challenging to take their medications, and alternatives should be offered. Often, herbal treatments and over-the-counter medications are forgotten and might contribute to unexpected events.<xref ref-type="bibr" rid="article-148032.r16">[16]</xref></p>
        <p>
<bold>Medication Reconciliation</bold>
</p>
        <p>Medication reconciliation is another technique for evaluating polypharmacy and appropriate prescriptions without sacrificing time. It entails asking the patients to bring a list of all their medications or the actual bottles (also known as the brown bag assessment) to a consultation. This&#x000a0;practice is often very revealing and&#x000a0;results in discovering potential risks for medication errors, including duplicate bottles of the same medication at different dosages, discovering medications prescribed by other providers, and medications the patient forgot to mention as they may use them intermittently. The American Geriatrics Society recommends only prescribing new drugs after reviewing all of a patient's medications.<xref ref-type="bibr" rid="article-148032.r15">[15]</xref></p>
        <p>
<bold>Deprescribing</bold>
</p>
        <p>Deprescribing is a necessary intervention that reduces harm and prevents adverse drug events; it is defined as reducing or discontinuing a medication. Treatment efficiency and minimal effective dosage are the goals of deprescribing.<xref ref-type="bibr" rid="article-148032.r21">[21]</xref><xref ref-type="bibr" rid="article-148032.r15">[15]</xref>&#x000a0;This process should be implemented whenever necessary, considering the evidence, patient preferences, and potential risks and benefits. Deprescribing should be seen as therapeutic, not as a harmful intervention. Interprofessional communication is essential to promote patient and provider confidence and achieve treatment goals.<xref ref-type="bibr" rid="article-148032.r21">[21]</xref><xref ref-type="bibr" rid="article-148032.r22">[22]</xref>&#x000a0;The Choosing Wisely Initiative and the Canadian Deprescribing Network are useful tools for safely deprescribing. Both aim to optimize treatments and reduce PIM use.<xref ref-type="bibr" rid="article-148032.r22">[22]</xref>&#x000a0;Another useful tool is the&#x000a0;ACB Calculator, an online calculator that can quantify the anticholinergic burden of multiple medications, individually and in combination, and&#x000a0;suggest safer alternatives.<xref ref-type="bibr" rid="article-148032.r23">[23]</xref>&#x000a0;Deprescribing should be systematically implemented, reducing patient hesitancy and improving acceptance.<xref ref-type="bibr" rid="article-148032.r15">[15]</xref></p>
      </sec>
      <sec id="article-148032.s6" sec-type="Other Issues">
        <title>Other Issues</title>
        <p>
<bold>Limitations to the&#x000a0;AGS Beers Criteria&#x000ae;</bold>
</p>
        <p>The AGS Beers Criteria&#x000ae; complements clinical judgment and decision-making and should not be used independently to add or remove medications for patients. Treatment should be individualized, understanding that patients are complex and conditions differ between individuals<bold>.</bold><xref ref-type="bibr" rid="article-148032.r3">[3]</xref>&#x000a0;The AGS Beers Criteria&#x000ae; does&#x000a0;not always apply to hospitalized and palliative care patients. Risk-benefit ratios vary in these settings, and there are innumerable scenarios to consider.<xref ref-type="bibr" rid="article-148032.r3">[3]</xref><xref ref-type="bibr" rid="article-148032.r4">[4]</xref>&#x000a0;Finally, the AGS Beers Criteria&#x000ae; was validated using evidence from&#x000a0;the United States and is not necessarily applicable in all countries.<xref ref-type="bibr" rid="article-148032.r3">[3]</xref></p>
      </sec>
      <sec id="article-148032.s7" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The AGS Beers Criteria&#x000ae; was developed to be&#x000a0;utilized&#x000a0;in an interprofessional, patient-centered approach to avoid adverse drug events and assess the prescription of PIM. Clinicians, pharmacists, nurses, and other professionals should be involved in the integral care of geriatric patients.<xref ref-type="bibr" rid="article-148032.r3">[3]</xref>&#x000a0;Several studies have shown that using real-world data based on direct measurements improves patient outcomes and reduces adverse drug events. Databases such as FAERS, WHO VigiBase, and the SYMPATHY Project provide useful information for implementing safe prescribing strategies.<xref ref-type="bibr" rid="article-148032.r9">[9]</xref><xref ref-type="bibr" rid="article-148032.r6">[6]</xref><xref ref-type="bibr" rid="article-148032.r10">[10]</xref>&#x000a0;Physicians play an essential role in prescriptions. Nonetheless, it is often challenging for medical professionals to monitor patients' behaviors and global health. Nurses are better positioned to follow patients and understand changes in health status closely. Pharmacists have a deep understanding of medications.<xref ref-type="bibr" rid="article-148032.r24">[24]</xref>&#x000a0;In a study conducted in Malaysia, awareness of the&#x000a0;AGS Beers Criteria&#x000ae; was less than 40% among pharmacists, meaning that prescriptions were filled without further assessment. Interdisciplinary education and familiarity with the&#x000a0;AGS Beers Criteria&#x000ae;&#x000a0;are crucial to utilizing system-based review and reducing PIM prescriptions. Promoting pharmacist review of medications, assuming their familiarity with the&#x000a0;AGS Beers Criteria&#x000ae;, is a simple intervention that could reduce mistakes.<xref ref-type="bibr" rid="article-148032.r25">[25]</xref></p>
        <p>The Finnish Interprofessional Medication Assessment was a randomized controlled trial that compared adverse drug events when assessing medications with an interprofessional team&#x000a0;versus&#x000a0;a conventional approach. The intervention resulted in a statistically significant decrease in adverse events.<xref ref-type="bibr" rid="article-148032.r26">[26]</xref>&#x000a0;Another study showed that when utilizing multiple tools to assess medications and a pharmacist-led deprescribing approach, the identification of PIM increased considerably.<xref ref-type="bibr" rid="article-148032.r22">[22]</xref>&#x000a0;When collaboration is encouraged, medication management is simplified, and risks are minimized.<xref ref-type="bibr" rid="article-148032.r24">[24]</xref>&#x000a0;Physicians should be in constant, reciprocal communication with patients and other professionals. Adequate care transfer helps address barriers and limitations that could harm patients.<xref ref-type="bibr" rid="article-148032.r6">[6]</xref>&#x000a0;Appropriately prescribing medications is a key intervention to improve patient outcomes. Medical knowledge is not sufficient to guarantee the elimination of harmful medications. Interprofessional&#x000a0;collaboration&#x000a0;is essential to achieve the goals of care. Prescriber education, feedback and auditing, and clinical decision support tools should be systematically implemented to improve healthcare practices.<xref ref-type="bibr" rid="article-148032.r24">[24]</xref><xref ref-type="bibr" rid="article-148032.r21">[21]</xref><xref ref-type="bibr" rid="article-148032.r20">[20]</xref></p>
      </sec>
      <sec id="article-148032.s8">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=148032&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=148032">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/148032/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=148032">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-148032.s9">
        <title>References</title>
        <ref id="article-148032.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdelwahed</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>El-Dahiyat</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Aljawamis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Al Ajimi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bin Rafeea</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Potentially inappropriate medications in older adults according to Beers criteria 2019: Prevalence and risk factors.</article-title>
            <source>Int J Clin Pract</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>75</volume>
            <issue>11</issue>
            <fpage>e14715</fpage>
            <pub-id pub-id-type="pmid">34378294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Viana</surname>
                <given-names>SSC</given-names>
              </name>
              <name>
                <surname>Souza</surname>
                <given-names>NPDS</given-names>
              </name>
              <name>
                <surname>Aliberti</surname>
                <given-names>MJR</given-names>
              </name>
              <name>
                <surname>Jacob-Filho</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Use of potentially inappropriate medications and adverse events in older outpatients with acute conditions.</article-title>
            <source>Einstein (Sao Paulo)</source>
            <year>2022</year>
            <volume>20</volume>
            <fpage>eAO8024</fpage>
            <pub-id pub-id-type="pmid">35792759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <collab>By the 2019 American Geriatrics Society Beers Criteria&#x000ae; Update Expert Panel</collab>
            <article-title>American Geriatrics Society 2019 Updated AGS Beers Criteria&#x000ae; for Potentially Inappropriate Medication Use in Older Adults.</article-title>
            <source>J Am Geriatr Soc</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>674</fpage>
            <page-range>674-694</page-range>
            <pub-id pub-id-type="pmid">30693946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <collab>By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel</collab>
            <article-title>American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.</article-title>
            <source>J Am Geriatr Soc</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>63</volume>
            <issue>11</issue>
            <fpage>2227</fpage>
            <page-range>2227-46</page-range>
            <pub-id pub-id-type="pmid">26446832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Connor</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Gallagher</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>O'Mahony</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Inappropriate prescribing: criteria, detection and prevention.</article-title>
            <source>Drugs Aging</source>
            <year>2012</year>
            <month>Jun</month>
            <day>01</day>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>437</fpage>
            <page-range>437-52</page-range>
            <pub-id pub-id-type="pmid">22642779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baruth</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Gentry</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Rummans</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Polypharmacy in older adults: the role of the multidisciplinary team.</article-title>
            <source>Hosp Pract (1995)</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>48</volume>
            <issue>sup1</issue>
            <fpage>56</fpage>
            <page-range>56-62</page-range>
            <pub-id pub-id-type="pmid">31900000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lund</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Carnahan</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Egge</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Chrischilles</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Kaboli</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Inappropriate prescribing predicts adverse drug events in older adults.</article-title>
            <source>Ann Pharmacother</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>44</volume>
            <issue>6</issue>
            <fpage>957</fpage>
            <page-range>957-63</page-range>
            <pub-id pub-id-type="pmid">20460558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suehs</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Gooch</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Impact of 2015 Update to the Beers Criteria on Estimates of Prevalence and Costs Associated with Potentially Inappropriate Use of Antimuscarinics for Overactive Bladder.</article-title>
            <source>Drugs Aging</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>34</volume>
            <issue>7</issue>
            <fpage>535</fpage>
            <page-range>535-543</page-range>
            <pub-id pub-id-type="pmid">28540648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shao</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Research on Beers Criteria and STOPP/START Criteria based on the FDA FAERS database.</article-title>
            <source>Eur J Clin Pharmacol</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>77</volume>
            <issue>8</issue>
            <fpage>1147</fpage>
            <page-range>1147-1156</page-range>
            <pub-id pub-id-type="pmid">34170370</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Geriatrics on beers criteria medications at risk of adverse drug events using real-world data.</article-title>
            <source>Int J Med Inform</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>154</volume>
            <fpage>104542</fpage>
            <pub-id pub-id-type="pmid">34411951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolff</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Adler</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Weinstein</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Managing Nocturia in Frail Older Adults.</article-title>
            <source>Drugs Aging</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>95</fpage>
            <page-range>95-109</page-range>
            <pub-id pub-id-type="pmid">33230803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000f6;ffler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Drewelow</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Paschka</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Frankenstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jatsch</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reisinger</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Hallauer</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Drewelow</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Heidorn</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schr&#x000f6;der</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wollny</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kundt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Altiner</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Optimizing polypharmacy among elderly hospital patients with chronic diseases--study protocol of the cluster randomized controlled POLITE-RCT trial.</article-title>
            <source>Implement Sci</source>
            <year>2014</year>
            <month>Oct</month>
            <day>06</day>
            <volume>9</volume>
            <fpage>151</fpage>
            <pub-id pub-id-type="pmid">25287853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Storms</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Marquet</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Aertgeerts</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Claes</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of inappropriate medication use in residential long-term care facilities for the elderly: A systematic review.</article-title>
            <source>Eur J Gen Pract</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-77</page-range>
            <pub-id pub-id-type="pmid">28271916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chhabra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Arora</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clonazepam tops the list of potentially inappropriate psychotropic (PIP) medications in older adults with psychiatric illness: A cross-sectional study based on Beers criteria 2019 vs STOPP criteria 2015.</article-title>
            <source>Asian J Psychiatr</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>58</volume>
            <fpage>102570</fpage>
            <pub-id pub-id-type="pmid">33618072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Halli-Tierney</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Scarbrough</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Polypharmacy: Evaluating Risks and Deprescribing.</article-title>
            <source>Am Fam Physician</source>
            <year>2019</year>
            <month>Jul</month>
            <day>01</day>
            <volume>100</volume>
            <issue>1</issue>
            <fpage>32</fpage>
            <page-range>32-38</page-range>
            <pub-id pub-id-type="pmid">31259501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antimisiaris</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cutler</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Managing Polypharmacy in the 15-Minute Office Visit.</article-title>
            <source>Prim Care</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>413</fpage>
            <page-range>413-428</page-range>
            <pub-id pub-id-type="pmid">28797369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levy</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>Polypharmacy Reduction Strategies: Tips on Incorporating American Geriatrics Society Beers and Screening Tool of Older People's Prescriptions Criteria.</article-title>
            <source>Clin Geriatr Med</source>
            <year>2017</year>
            <month>May</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>177</fpage>
            <page-range>177-187</page-range>
            <pub-id pub-id-type="pmid">28364990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeRhodes</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>The Dangers of Ignoring the Beers Criteria-The Prescribing Cascade.</article-title>
            <source>JAMA Intern Med</source>
            <year>2019</year>
            <month>Jul</month>
            <day>01</day>
            <volume>179</volume>
            <issue>7</issue>
            <fpage>863</fpage>
            <page-range>863-864</page-range>
            <pub-id pub-id-type="pmid">31081879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steinman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Fick</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Using Wisely: A Reminder on How to Properly Use the American Geriatrics Society Beers Criteria<sup>&#x000ae;</sup>.</article-title>
            <source>J Gerontol Nurs</source>
            <year>2019</year>
            <month>Mar</month>
            <day>01</day>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>3</fpage>
            <page-range>3-6</page-range>
            <pub-id pub-id-type="pmid">30789983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steinman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Beizer</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>DuBeau</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Laird</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Lundebjerg</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Mulhausen</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>How to Use the American Geriatrics Society 2015 Beers Criteria-A Guide for Patients, Clinicians, Health Systems, and Payors.</article-title>
            <source>J Am Geriatr Soc</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>63</volume>
            <issue>12</issue>
            <fpage>e1</fpage>
            <page-range>e1-e7</page-range>
            <pub-id pub-id-type="pmid">26446776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Earl</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Katapodis</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Schneiderman</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Shoemaker-Hunt</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.</article-title>
            <source>J Patient Saf</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>3S Suppl 1</issue>
            <fpage>S23</fpage>
            <page-range>S23-S35</page-range>
            <pub-id pub-id-type="pmid">32809998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Whitman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>DeGregory</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mohile</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ramsdale</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.</article-title>
            <source>Support Care Cancer</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>26</volume>
            <issue>12</issue>
            <fpage>4105</fpage>
            <page-range>4105-4113</page-range>
            <pub-id pub-id-type="pmid">29869294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Villalba-Moreno</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Alfaro-Lara</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Fidalgo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nieto-Mart&#x000ed;n</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Santos-Ramos</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Development of the Anticholinergic Burden Calculator Web Tool.</article-title>
            <source>Farm Hosp</source>
            <year>2017</year>
            <month>Sep</month>
            <day>01</day>
            <volume>41</volume>
            <issue>5</issue>
            <fpage>647</fpage>
            <page-range>647-648</page-range>
            <pub-id pub-id-type="pmid">28847259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krause</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Wiese</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Kirsch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Th&#x000fc;rmann</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wilm</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sparenberg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Stolz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Freytag</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bleidorn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Junius-Walker</surname>
                <given-names>U</given-names>
              </name>
              <collab>HIOPP-3-iTBX study group</collab>
            </person-group>
            <article-title>Multidisciplinary intervention to improve medication safety in nursing home residents: protocol of a cluster randomised controlled trial (HIOPP-3-iTBX study).</article-title>
            <source>BMC Geriatr</source>
            <year>2019</year>
            <month>Jan</month>
            <day>25</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <pub-id pub-id-type="pmid">30683060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foong</surname>
                <given-names>RTK</given-names>
              </name>
              <name>
                <surname>Sellappans</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Loo</surname>
                <given-names>JSE</given-names>
              </name>
            </person-group>
            <article-title>Awareness of Beers Criteria and knowledge of potentially inappropriate medications among community pharmacists in the Klang Valley, Malaysia.</article-title>
            <source>J Eval Clin Pract</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>165</fpage>
            <page-range>165-171</page-range>
            <pub-id pub-id-type="pmid">31168913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148032.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Auvinen</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>R&#x000e4;is&#x000e4;nen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Voutilainen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jyrkk&#x000e4;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>M&#x000e4;ntyselk&#x000e4;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>L&#x000f6;nnroos</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Interprofessional Medication Assessment has Effects on the Quality of Medication Among Home Care Patients: Randomized Controlled Intervention Study.</article-title>
            <source>J Am Med Dir Assoc</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>74</fpage>
            <page-range>74-81</page-range>
            <pub-id pub-id-type="pmid">32893136</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
